Clinical Uses of a2-Adrenergic Agonists
Clinical Uses of a2-Adrenergic Agonists
复制标题
α2-肾上腺素能激动剂的临床用途
DOI：
--
复制
发表时间：
2000
期刊：
影响因子：
--
通讯作者：
R. Weiskopf
中科院分区：
文献类型：
--
作者：
R. Weiskopf
本月的《临床概念与评论》是由a2激动剂的主要权威之一Mervyn Maze博士合著的一篇文章。梅兹博士也是位于伊利诺伊州雅培公园的雅培实验室公司的顾问，并在该公司开发a2激动剂右美托咪定的过程中发挥了重要作用，该药最近已被批准在美国进行有限的使用。这引发了潜在的利益冲突，这是本刊编辑委员会长期以来一直关注的一个问题。委员会认识到，对于作者的意见和引文的选择是突出特点的文章，有关于利益冲突的特殊考虑。这篇文章是在广泛的编辑意见的基础上编写的，以确保平衡和客观，我们希望这将使我们的读者获得最大的教育效益。
This month’s Clinical Concepts and Commentary is composed of an article coauthored by Dr. Mervyn Maze, one of the leading authorities in a2 agonists. Dr. Maze is also a consultant for Abbott Laboratories Inc., Abbott Park, Illinois, and played a major role in that company’s development of dexmedetomidine, an a2 agonist, which recently has been approved for limited use in the United States. This raises a potential conflict of interest, an issue about which this journal’s editorial board has had a long record of concern. The board recognizes that there is a special consideration regarding conflict of interest for articles in which an author’s opinions and selection of citations are a prominent feature. This article was prepared with extensive editorial input to ensure balance and objectivity, which we hope will enable our readers to derive the maximum educational benefit.
影响因子：
8.3
作者：
Makaritsis, KP;Johns, C;Gavras, H
通讯作者：
Gavras, H
DOI：
10.1073/pnas.94.18.9950
发表时间：
1997-09-02
影响因子：
11.1
作者：
Lakhlani, PP;MacMillan, LB;Limbird, LE
通讯作者：
Limbird, LE